Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bone|November 15, 2016
Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA studyJ N Tsai, S M Burnett-Bowie, H Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in menB Z Leder, M R Smith, M A Fallon, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Metabolism of orally administered androstenedione in young menB Z Leder, D H Catlin, C Longcope, et al.
JAMA|February 22, 2000
Oral androstenedione administration and serum testosterone concentrations in young menB Z Leder, C Longcope, D H Catlin, et al.
JAMA|November 22, 2000
Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metaboliteD H Catlin, B Z Leder, B Ahrens, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2019
Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practiceH Lyu, K Yoshida, S K Tedeschi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 24, 2017
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trialJ P Bilezikian, G Hattersley, L A Fitzpatrick, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2016
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)J N Tsai, A V Uihlein, S M Burnett-Bowie, et al.
Pageof 1